Cambiar Investors LLC Has $2.28 Million Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Cambiar Investors LLC lowered its stake in HealthEquity, Inc. (NASDAQ:HQY) by 87.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 23,780 shares of the company’s stock after selling 164,965 shares during the quarter. Cambiar Investors LLC’s holdings in HealthEquity were worth $2,282,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in HQY. Paladin Wealth LLC bought a new stake in shares of HealthEquity in the 3rd quarter valued at $39,000. UMB Bank n.a. increased its position in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after buying an additional 164 shares in the last quarter. GAMMA Investing LLC increased its position in shares of HealthEquity by 57.8% in the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock valued at $77,000 after buying an additional 344 shares in the last quarter. Quarry LP increased its position in shares of HealthEquity by 418.8% in the 3rd quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after buying an additional 1,089 shares in the last quarter. Finally, 1620 Investment Advisors Inc. bought a new stake in shares of HealthEquity in the 3rd quarter valued at $112,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $112.15 on Tuesday. The stock has a market capitalization of $9.72 billion, a price-to-earnings ratio of 102.89, a PEG ratio of 1.61 and a beta of 0.55. The business has a 50-day moving average of $101.18 and a 200-day moving average of $89.98. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $113.61.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter last year, the company earned $0.40 earnings per share. As a group, sell-side analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

HQY has been the subject of a number of recent analyst reports. BTIG Research upped their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research report on Thursday, November 14th. The Goldman Sachs Group started coverage on shares of HealthEquity in a research report on Friday, November 15th. They issued a “neutral” rating and a $108.00 price objective for the company. Bank of America increased their target price on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Mizuho started coverage on HealthEquity in a report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price for the company. Finally, JMP Securities increased their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $110.71.

Insider Activity at HealthEquity

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the sale, the director now directly owns 19,061 shares in the company, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $101.56, for a total transaction of $837,870.00. Following the sale, the director now owns 66,469 shares of the company’s stock, valued at $6,750,591.64. This trade represents a 11.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.